Advertisement
Screener

Corvus Pharmaceuticals, Inc. (CRVS) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

Corvus Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Corvus Pharmaceuticals, Inc. (CRVS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $4.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.54M, a 2821.84% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.76M.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $204.00K, a 82.53% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$64.00K, a 128.70% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$941.00K, a 159.29% decline from fiscal 2024.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.59M, a 19737.50% increase from fiscal 2023.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $8.00K.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$581.00K, a 309.75% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 11 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month
2026-06-30$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$4.30M
10-Q · filed 2026-08-06
$4.51M
derived: sum of 3 quarters · filed 2026-08-06
$4.44M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.76M
10-Q · filed 2026-05-07
$1.97M
derived: sum of 2 quarters · filed 2026-05-07
$1.90M
derived: sum of 3 quarters · filed 2026-05-07
$1.99M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$204.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$140.00K
derived: sum of 2 quarters · filed 2026-03-12
$227.00K
derived: sum of 3 quarters · filed 2026-08-06
-$941.00K
10-K · filed 2026-03-12
2025-09-30-$64.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$23.00K
derived: sum of 2 quarters · filed 2026-08-06
-$1.15M
10-Q · filed 2025-11-04
$23.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$87.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.08M
10-Q · filed 2026-08-06
$87.00K
derived: sum of 3 quarters · filed 2026-08-06
$310.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$1.17M
10-Q · filed 2026-05-07
$0.00
derived: sum of 2 quarters · filed 2026-05-07
$223.00K
derived: sum of 3 quarters · filed 2026-05-07
$503.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$1.39M
derived: sum of 2 quarters · filed 2026-03-12
$1.67M
derived: sum of 3 quarters · filed 2026-03-12
$1.59M
10-K · filed 2026-03-12
2024-09-30$223.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$503.00K
derived: sum of 2 quarters · filed 2025-11-04
$419.00K
10-Q · filed 2025-11-04
$285.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30$280.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$196.00K
10-Q · filed 2025-08-07
$62.00K
derived: sum of 3 quarters · filed 2026-03-12
$84.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31-$84.00K
10-Q · filed 2025-05-08
-$218.00K
derived: sum of 2 quarters · filed 2026-03-12
-$196.00K
derived: sum of 3 quarters · filed 2026-03-12
$42.00K
derived: sum of 4 quarters · filed 2026-03-12
2023-12-31-$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$112.00K
derived: sum of 2 quarters · filed 2026-03-12
$126.00K
derived: sum of 3 quarters · filed 2026-03-12
$8.00K
10-K · filed 2026-03-12
2023-09-30$22.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$260.00K
derived: sum of 2 quarters · filed 2024-11-12
$142.00K
10-Q · filed 2024-11-12
-$237.00K
derived: sum of 4 quarters · filed 2025-03-25
2023-06-30$238.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$120.00K
10-Q · filed 2024-08-06
-$259.00K
derived: sum of 3 quarters · filed 2025-03-25
-$896.00K
derived: sum of 4 quarters · filed 2025-03-25
2023-03-31-$118.00K
10-Q · filed 2024-05-07
-$497.00K
derived: sum of 2 quarters · filed 2025-03-25
-$1.13M
derived: sum of 3 quarters · filed 2025-03-25
-$395.00K
derived: sum of 4 quarters · filed 2025-03-25
2022-12-31-$379.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
-$1.02M
derived: sum of 2 quarters · filed 2025-03-25
-$277.00K
derived: sum of 3 quarters · filed 2025-03-25
-$581.00K
10-K · filed 2025-03-25
2022-09-30-$637.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$102.00K
derived: sum of 2 quarters · filed 2023-11-07
-$202.00K
10-Q · filed 2023-11-07
-$1.00M
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30$739.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$435.00K
10-Q · filed 2023-08-08
-$363.00K
derived: sum of 3 quarters · filed 2024-03-19
-$868.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31-$304.00K
10-Q · filed 2023-05-08
-$1.10M
derived: sum of 2 quarters · filed 2024-03-19
-$1.61M
derived: sum of 3 quarters · filed 2024-03-19
$210.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31-$798.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$1.30M
derived: sum of 2 quarters · filed 2024-03-19
$514.00K
derived: sum of 3 quarters · filed 2024-03-19
$277.00K
10-K · filed 2024-03-19
2021-09-30-$505.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$1.31M
derived: sum of 2 quarters · filed 2022-11-03
$1.07M
10-Q · filed 2022-11-03
$1.00M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30$1.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$1.58M
10-Q · filed 2022-08-08
$1.58M
10-Q · filed 2021-08-02
$1.51M
derived: sum of 3 quarters · filed 2023-03-28
$1.35M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31-$237.00K
10-Q · filed 2022-05-05
-$308.00K
derived: sum of 2 quarters · filed 2023-03-28
-$463.00K
derived: sum of 3 quarters · filed 2023-03-28
-$296.00K
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31-$71.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$226.00K
derived: sum of 2 quarters · filed 2023-03-28
-$59.00K
derived: sum of 3 quarters · filed 2023-03-28
-$285.00K
10-K · filed 2023-03-28
2020-09-30-$155.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01
$12.00K
derived: sum of 2 quarters · filed 2021-11-01
-$214.00K
10-Q · filed 2021-11-01
-$263.00K
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30$167.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02
-$59.00K
10-Q · filed 2021-08-02
-$108.00K
derived: sum of 3 quarters · filed 2022-03-10
-$2.00K
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31-$226.00K
10-Q · filed 2021-04-29
-$275.00K
derived: sum of 2 quarters · filed 2022-03-10
-$169.00K
derived: sum of 3 quarters · filed 2022-03-10
-$61.00K
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31-$49.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$57.00K
derived: sum of 2 quarters · filed 2022-03-10
$165.00K
derived: sum of 3 quarters · filed 2022-03-10
$370.00K
10-K · filed 2022-03-10
2019-09-30$106.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$214.00K
derived: sum of 2 quarters · filed 2020-10-29
$419.00K
10-Q · filed 2020-10-29
-$476.00K
derived: sum of 4 quarters · filed 2021-03-25
2019-06-30$108.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$313.00K
10-Q · filed 2020-07-30
-$582.00K
derived: sum of 3 quarters · filed 2021-03-25
$117.00K
derived: sum of 4 quarters · filed 2021-03-25
2019-03-31$205.00K
10-Q · filed 2020-04-30
-$690.00K
derived: sum of 2 quarters · filed 2021-03-25
$9.00K
derived: sum of 3 quarters · filed 2021-03-25
-$35.00K
derived: sum of 4 quarters · filed 2021-03-25
2018-12-31-$895.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$196.00K
derived: sum of 2 quarters · filed 2021-03-25
-$240.00K
derived: sum of 3 quarters · filed 2021-03-25
-$187.00K
10-K · filed 2021-03-25
2018-09-30$699.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29
$655.00K
derived: sum of 2 quarters · filed 2019-10-29
$708.00K
10-Q · filed 2019-10-29
$747.00K
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30-$44.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$9.00K
10-Q · filed 2019-08-01
$48.00K
derived: sum of 3 quarters · filed 2020-03-09
-$131.00K
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31$53.00K
10-Q · filed 2019-05-09
$92.00K
derived: sum of 2 quarters · filed 2020-03-09
-$87.00K
derived: sum of 3 quarters · filed 2020-03-09
$160.00K
derived: sum of 4 quarters · filed 2020-03-09
2017-12-31$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
-$140.00K
derived: sum of 2 quarters · filed 2020-03-09
$107.00K
derived: sum of 3 quarters · filed 2020-03-09
$44.00K
10-K · filed 2020-03-09
2017-09-30-$179.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$68.00K
derived: sum of 2 quarters · filed 2018-11-01
$5.00K
10-Q · filed 2018-11-01
$228.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$247.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$184.00K
10-Q · filed 2018-08-02
$407.00K
derived: sum of 3 quarters · filed 2019-03-07
-$22.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$63.00K
10-Q · filed 2018-05-03
$160.00K
derived: sum of 2 quarters · filed 2019-03-07
-$269.00K
derived: sum of 3 quarters · filed 2019-03-07
-$700.00K
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$223.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$206.00K
derived: sum of 2 quarters · filed 2019-03-07
-$637.00K
derived: sum of 3 quarters · filed 2019-03-07
-$290.00K
10-K · filed 2019-03-07
2016-09-30-$429.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$860.00K
derived: sum of 2 quarters · filed 2017-11-02
-$513.00K
10-Q · filed 2017-11-02
-$12.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$431.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$84.00K
10-Q · filed 2017-08-03
$417.00K
derived: sum of 3 quarters · filed 2018-03-01
$978.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$347.00K
10-Q · filed 2017-05-04
$848.00K
derived: sum of 2 quarters · filed 2018-03-01
$1.41M
derived: sum of 3 quarters · filed 2018-03-01
$1.41M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$501.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.06M
derived: sum of 2 quarters · filed 2018-03-01
$1.07M
derived: sum of 3 quarters · filed 2018-03-01
$1.26M
10-K · filed 2018-03-01
2015-09-30$561.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$566.00K
derived: sum of 2 quarters · filed 2016-11-03
$764.00K
10-Q · filed 2016-11-03
2015-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$203.00K
10-Q · filed 2016-08-04
2015-03-31$198.00K
10-Q · filed 2016-05-05
2014-12-31$12.00K
10-K · filed 2017-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Apnimed, Inc. (APMD)United States$0.899B